ClinicalTrials.Veeva

Menu

Obesity-asthma Endophenotype and Diaphragm Mobility in Adolescence

U

Universidade Federal de Pernambuco

Status

Completed

Conditions

Asthma
Obesity

Study type

Observational

Funder types

Other

Identifiers

NCT03029936
43599215.4.0000.5208

Details and patient eligibility

About

Obesity and asthma share changes that may begin in the fetal development phase. The endophenotype obesity-asthma presents as main characteristic a pattern of inflammatory response different from the habitual Th2 profile of cytokines. In these obese patients, possible changes in the diaphragm muscle can directly influence the dynamics of pulmonary ventilation significantly.

Due to the importance of the diaphragm in pulmonary ventilation, this study will be performed to verify possible alteration in the excursion and diaphragmatic thickness of adolescents with endophenotype obesity-asthma. In parallel, the possible underlying etiopathogenic substrate of this endophenotype will be explored through the dosing of muscle enzymes and inflammatory cytokines and obesity hormones.

Enrollment

100 patients

Sex

All

Ages

12 to 21 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adolescents of both sexes, aged 12-21 years;
  • For the obesity groups, BMI for gender and age equal to or greater than the 97th percentile;
  • Clinical diagnosis of persistent, moderate and severe asthma by a specialist physician and its severity classified according to the GINA (Global Initiative Against Asthma) criteria.

Exclusion criteria

  • Adolescents with a diagnosis of cardiovascular, rheumatic, osteoarticular, neuromuscular or any other disease that limits the safe performance of the tests proposed by the protocol will be excluded; And those who do not agree to participate in the study.

Trial design

100 participants in 4 patient groups

Obesity Group
Asthma Group
Obesity-Asthma Group
Control

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems